EZH2 and cholangiocarcinoma: The enhancer of zeste homologue 2 (EZH2) is a recently used marker for hepatocellular carcinomas, but it can also be used in the treatment of cholangiocellular carcinomas as it is able to differentiate between neoplastic or benign (or reactive) biliary proliferation [25].